1to2: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
|PDB= 1to2 |SIZE=350|CAPTION= <scene name='initialview01'>1to2</scene>, resolution 1.30Å | |PDB= 1to2 |SIZE=350|CAPTION= <scene name='initialview01'>1to2</scene>, resolution 1.30Å | ||
|SITE= | |SITE= | ||
|LIGAND= <scene name='pdbligand= | |LIGAND= <scene name='pdbligand=15P:POLYETHYLENE+GLYCOL+(N=34)'>15P</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=NA:SODIUM+ION'>NA</scene> | ||
|ACTIVITY= [http://en.wikipedia.org/wiki/Subtilisin Subtilisin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.62 3.4.21.62] | |ACTIVITY= <span class='plainlinks'>[http://en.wikipedia.org/wiki/Subtilisin Subtilisin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.62 3.4.21.62] </span> | ||
|GENE= APR ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1390 Bacillus amyloliquefaciens]) | |GENE= APR ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=1390 Bacillus amyloliquefaciens]) | ||
|DOMAIN= | |||
|RELATEDENTRY=[[1tm1|1TM1]], [[1tm3|1TM3]], [[1tm4|1TM4]], [[1tm5|1TM5]], [[1tm7|1TM7]], [[1tmg|1TMG]], [[1to1|1TO1]] | |||
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1to2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1to2 OCA], [http://www.ebi.ac.uk/pdbsum/1to2 PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1to2 RCSB]</span> | |||
}} | }} | ||
Line 28: | Line 31: | ||
[[Category: Lu, C J.Karen.]] | [[Category: Lu, C J.Karen.]] | ||
[[Category: Radisky, E S.]] | [[Category: Radisky, E S.]] | ||
[[Category: inhibitor]] | [[Category: inhibitor]] | ||
[[Category: serine protease]] | [[Category: serine protease]] | ||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 23:58:50 2008'' |
Revision as of 23:58, 30 March 2008
| |||||||
, resolution 1.30Å | |||||||
---|---|---|---|---|---|---|---|
Ligands: | , , , | ||||||
Gene: | APR (Bacillus amyloliquefaciens) | ||||||
Activity: | Subtilisin, with EC number 3.4.21.62 | ||||||
Related: | 1TM1, 1TM3, 1TM4, 1TM5, 1TM7, 1TMG, 1TO1
| ||||||
Resources: | FirstGlance, OCA, PDBsum, RCSB | ||||||
Coordinates: | save as pdb, mmCIF, xml |
crystal structure of the complex of subtilisin BPN' with chymotrypsin inhibitor 2 M59K, in pH 9 cryosoak
OverviewOverview
A series of mutants of chymotrypsin inhibitor 2 (CI2), at residues that interact with the inhibited enzyme subtilisin BPN', were studied to determine the relative importance of intermolecular contacts on either side of the scissile bond. Mutants were tested for inhibition of subtilisin, rates of hydrolysis by subtilisin, and ability to acylate subtilisin. Additionally, crystal structures of the mutant CI2 complexes with subtilisin were obtained. Ordered water molecules were found to play an important role in inhibitor recognition, and features of the crystal structures, in combination with biochemical data, support a transition-state stabilization role for the P(1) residue in subtilisin catalysis. Consistent with the proposed mechanism of inhibition, in which rapid acylation is followed by religation, leaving-group contacts with the enzyme were found to be more critical determinants of inhibition than acylating-group contacts in the mutants studied here.
About this StructureAbout this Structure
1TO2 is a Protein complex structure of sequences from Bacillus amyloliquefaciens and Hordeum vulgare subsp. vulgare. Full crystallographic information is available from OCA.
ReferenceReference
Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex., Radisky ES, Kwan G, Karen Lu CJ, Koshland DE Jr, Biochemistry. 2004 Nov 2;43(43):13648-56. PMID:15504027
Page seeded by OCA on Sun Mar 30 23:58:50 2008